C9orf72 and amyotrophic lateral sclerosis: Furthermore, as the C9orf72-ALS patient lines used have a different genetic background compared to our isogenic lines, is possible that subtle converging dysfunctions that could have been detected in isogenicity are lost, particularly as differences between individuals are known to drive variation in iPSCs, both in differentiation capacity and morphology73.